Psorizide Forte Tablet
NDC Package 61480-255-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Psorizide Forte (nickel sulfate, potassium bromide, and fumaric acid) tablets is pSORIZIDE® Forte is indicated for the treatment of contact dermatitis due to nickel (metal/jewelry allergy,) dyshidrotic hand/foot eczema, and mild to severe psoriasis. This formulation utilizes a tablet delivery system. Marketed by Plymouth Healthcare Products Llc, this product is identified by NDC 61480-255.

Identification & Billing

NDC Package Code
61480-255-05
Package Description
90 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
61480025505
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
90 EA

Clinical Specifications

Proprietary Name
Psorizide Forte
Non-Proprietary Name
Nickel Sulfate, Potassium Bromide, And Fumaric Acid
Substance Name
Fumaric Acid; Nickel Sulfate; Potassium Bromide
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
PSORIZIDE® Forte is indicated for the treatment of contact dermatitis due to nickel (metal/jewelry allergy,) dyshidrotic hand/foot eczema, and mild to severe psoriasis. It has been found to work well with a variety of combination therapies. Eczema, seborrhea and a variety of chronic pruritic inflammatory dermatoses generally respond well also.

Regulatory & Marketing

Labeler Name
Plymouth Healthcare Products Llc
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
11-15-2001
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61480-255-05 identifies a specific commercial package of 90 tablet in 1 bottle of Psorizide Forte, a human prescription drug labeled by Plymouth Healthcare Products Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 90 billable units per package. This tablet is formulated for oral use and contains fumaric acid; nickel sulfate; potassium bromide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Plymouth Healthcare Products Llc on November 15, 2001. The current certification is valid through December 31, 2026.

How is this Plymouth Healthcare Products Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61480025505. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61480-255-05
11-Digit CMS (5-4-2)
61480-0255-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.